Management of high-risk localized prostate cancer: the integration of local and systemic therapy approaches
- 1 May 2003
- journal article
- review article
- Published by Elsevier BV in Urologic Oncology: Seminars and Original Investigations
- Vol. 21 (3), 235-243
- https://doi.org/10.1016/s1078-1439(03)00033-4
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- INDICATORS OF PATHOLOGIC STAGE OF PROSTATE CANCER AND THEIR USE IN CLINICAL PRACTICEUrologic Clinics of North America, 2001
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- USE OF GLEASON SCORE, PROSTATE SPECIFIC ANTIGEN, SEMINAL VESICLE AND MARGIN STATUS TO PREDICT BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMYJournal of Urology, 2001
- Analysis of recent trends in prostate cancer incidence and mortalityThe Prostate, 2000
- Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1999
- LONG-TERM SURVIVAL AFTER RADIOTHERAPY ALONE: RADIATION THERAPY ONCOLOGY GROUP PROSTATE CANCER TRIALSJournal of Urology, 1999
- The results of prostate carcinoma screening in the U. S. As reflected in the surveillance, epidemiology, and end results programCancer, 1997
- Changes in patterns of prostate cancer care in the United States: Results of American College of Surgeons Commission on Cancer Studies, 1974–1993The Prostate, 1997
- Follow-up Prostate Cancer Treatments After Radical Prostatectomy: a Population-Based StudyJNCI Journal of the National Cancer Institute, 1996
- Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment OutcomeJournal of Urology, 1994